# Terrestrial Energy Inc.: financial statements, quarterly

IMSR · Nasdaq · CIK 2019804 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imsr.md) · [Financials](/companies/imsr/financials.md) · [Filings](/companies/imsr/filings.md) · [Insiders](/companies/imsr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/imsr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | not reported | not reported | not reported | [1.4](/filings/0001104659-26-061234.md) | [1.4](/filings/0001104659-26-094085.md) | not reported | not reported | [4.6](/filings/0001104659-26-061234.md) | [3.5](/filings/0001104659-26-094085.md) |
| Operating income | $m | [(0.1)](/filings/0001213900-25-075067.md) | [(0.3)](/filings/0001213900-25-111005.md) | [(0.3) d](/filings/0001213900-25-064894.md) | [(4.9)](/filings/0001104659-26-061234.md) | [(5.2)](/filings/0001104659-26-094085.md) | [(1.6)](/filings/0001213900-25-111005.md) | [(21.0) d](/filings/0001104659-26-036846.md) | [(11.9)](/filings/0001104659-26-061234.md) | [(11.7)](/filings/0001104659-26-094085.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001104659-26-061234.md) | [0.0](/filings/0001104659-26-094085.md) | not reported | not reported | [0.0](/filings/0001104659-26-061234.md) | [0.1](/filings/0001104659-26-094085.md) |
| Net income | $m | [(0.1)](/filings/0001213900-25-111005.md) | [1.1](/filings/0001213900-25-111005.md) | [2.4 d](/filings/0001213900-25-064894.md) | [(6.3)](/filings/0001104659-26-061234.md) | [(6.2)](/filings/0001104659-26-094085.md) | [1.9](/filings/0001213900-25-111005.md) | [(31.2) d](/filings/0001104659-26-036846.md) | [(10.5)](/filings/0001104659-26-061234.md) | [(9.4)](/filings/0001104659-26-094085.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001213900-24-082719.md) | not reported | not reported | [(0.10)](/filings/0001104659-26-061234.md) | [(0.10)](/filings/0001104659-26-094085.md) | not reported | not reported | [(0.10)](/filings/0001104659-26-061234.md) | [(0.09)](/filings/0001104659-26-094085.md) |
| Basic EPS | $ per share | [(0.02)](/filings/0001213900-24-082719.md) | not reported | not reported | [(0.10)](/filings/0001104659-26-061234.md) | [(0.10)](/filings/0001104659-26-094085.md) | not reported | not reported | [(0.10)](/filings/0001104659-26-061234.md) | [(0.09)](/filings/0001104659-26-094085.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [0.8](/filings/0001213900-24-097511.md) | [3.0](/filings/0001104659-26-036846.md) | [0.5](/filings/0001213900-25-064899.md) | [0.1](/filings/0001213900-25-075067.md) | [0.4](/filings/0001213900-25-111005.md) | [97.2](/filings/0001104659-26-094085.md) | [76.9](/filings/0001104659-26-061234.md) | [131](/filings/0001104659-26-094085.md) |
| Current assets | $m | not reported | [0.0](/filings/0001213900-24-082719.md) | [1.0](/filings/0001213900-24-097511.md) | [3.3](/filings/0001104659-26-036846.md) | [0.7](/filings/0001213900-25-064899.md) | [0.3](/filings/0001213900-25-075067.md) | [0.5](/filings/0001213900-25-111005.md) | [300](/filings/0001104659-26-094085.md) | [277](/filings/0001104659-26-061234.md) | [275](/filings/0001104659-26-094085.md) |
| Total assets | $m | not reported | [0.4](/filings/0001213900-24-082719.md) | [234](/filings/0001213900-24-097511.md) | [5.3](/filings/0001104659-26-036846.md) | [238](/filings/0001213900-25-064899.md) | [240](/filings/0001213900-25-075067.md) | [243](/filings/0001213900-25-111005.md) | [303](/filings/0001104659-26-094085.md) | [295](/filings/0001104659-26-061234.md) | [290](/filings/0001104659-26-094085.md) |
| Current liabilities | $m | not reported | [0.4](/filings/0001213900-24-082719.md) | [0.4](/filings/0001213900-24-097511.md) | [1.1](/filings/0001104659-26-036846.md) | [1.4](/filings/0001213900-25-064899.md) | [2.5](/filings/0001213900-25-075067.md) | [4.3](/filings/0001213900-25-111005.md) | [5.9](/filings/0001104659-26-094085.md) | [5.0](/filings/0001104659-26-061234.md) | [6.2](/filings/0001104659-26-094085.md) |
| Total liabilities | $m | not reported | [0.4](/filings/0001213900-24-082719.md) | [11.1](/filings/0001213900-24-097511.md) | [18.8](/filings/0001104659-26-036846.md) | [12.8](/filings/0001213900-25-064899.md) | [14.3](/filings/0001213900-25-075067.md) | [15.0](/filings/0001213900-25-111005.md) | [7.6](/filings/0001104659-26-094085.md) | [6.6](/filings/0001104659-26-061234.md) | [8.2](/filings/0001104659-26-094085.md) |
| Short-term borrowings | $m | not reported | [0.2](/filings/0001213900-24-082719.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(4.9)](/filings/0001104659-26-036846.md) | [(0.0)](/filings/0001213900-25-111005.md) | [(10.0)](/filings/0001213900-25-111005.md) | [(10.3)](/filings/0001213900-25-111005.md) | [(12.1)](/filings/0001213900-25-111005.md) | [(14.0)](/filings/0001213900-25-111005.md) | [(14.5)](/filings/0001213900-25-111005.md) | [295](/filings/0001104659-26-094085.md) | [289](/filings/0001104659-26-061234.md) | [282](/filings/0001104659-26-094085.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.0) d](/filings/0001213900-25-064894.md) | [(2.8)](/filings/0001104659-26-061234.md) | [(4.1) d](/filings/0001104659-26-094085.md) | [5.8 d](/filings/0001213900-25-111005.md) | [(15.4) d](/filings/0001104659-26-036846.md) | [(9.1)](/filings/0001104659-26-061234.md) | [(5.7) d](/filings/0001104659-26-094085.md) |
| Capital expenditure | $m | not reported | [0.2](/filings/0001104659-26-061234.md) | [0.4 d](/filings/0001104659-26-094085.md) | not reported | not reported | [0.1](/filings/0001104659-26-061234.md) | [0.1 d](/filings/0001104659-26-094085.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.2](/filings/0001104659-26-061234.md) | [63.2](/filings/0001104659-26-094085.md) | [106](/filings/0001104659-26-061234.md) | [106](/filings/0001104659-26-094085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 105,935,254 at 2026-08-11, from the cover of the [10-Q filed 2026-08-11](/filings/0001104659-26-094085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.